{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:05:24Z","timestamp":1791925524940,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006415","name":"Stiftelsen Familjen Ernfors Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kocks stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004722","name":"Stiftelsen Lars Hiertas Minne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Diabetes Research Fund"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tore Nilssons foundation for medical research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00125-017-4286-3","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T09:55:07Z","timestamp":1494582907000},"page":"1522-1533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation"],"prefix":"10.1007","volume":"60","author":[{"given":"Klaudia","family":"Kulak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla T.","family":"Westermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Papac-Milicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Renstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben C.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"4286_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107","journal-title":"Nat Rev Immunol"},{"key":"4286_CR2","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","volume":"106","author":"JA Ehses","year":"2009","unstructured":"Ehses JA, Lacraz G, Giroix MH et al (2009) IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A 106:13998\u201314003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4286_CR3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","volume":"32","author":"CM Larsen","year":"2009","unstructured":"Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T (2009) Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32:1663\u20131668","journal-title":"Diabetes Care"},{"key":"4286_CR4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen CM, Faulenbach M, Vaag A et al (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517\u20131526","journal-title":"N Engl J Med"},{"key":"4286_CR5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn SE, DA DA, Schwartz MW et al (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by \u03b2-cells. Diabetes 39:634\u2013638","journal-title":"Diabetes"},{"key":"4286_CR6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat Immunol 11:897\u2013904","journal-title":"Nat Immunol"},{"key":"4286_CR7","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","volume":"178","author":"CA Jurgens","year":"2011","unstructured":"Jurgens CA, Toukatly MN, Fligner CL et al (2011) \u03b2-cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol 178:2632\u20132640","journal-title":"Am J Pathol"},{"key":"4286_CR8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491\u2013498","journal-title":"Diabetes"},{"key":"4286_CR9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2004.09.075","volume":"577","author":"E Sparr","year":"2004","unstructured":"Sparr E, Engel MF, Sakharov DV et al (2004) Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett 577:117\u2013120","journal-title":"FEBS Lett"},{"key":"4286_CR10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ et al (2013) CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14:812\u2013820","journal-title":"Nat Immunol"},{"key":"4286_CR11","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1074\/jbc.M111.244285","volume":"287","author":"J Sjolander","year":"2012","unstructured":"Sjolander J, Westermark GT, Renstrom E, Blom AM (2012) Islet amyloid polypeptide triggers limited complement activation and binds complement inhibitor C4b-binding protein, which enhances fibril formation. J Biol Chem 287:10824\u201310833","journal-title":"J Biol Chem"},{"key":"4286_CR12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC et al (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat Immunol 9:857\u2013865","journal-title":"Nat Immunol"},{"key":"4286_CR13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","volume":"17","author":"SL Masters","year":"2011","unstructured":"Masters SL, LA ON (2011) Disease-associated amyloid and misfolded protein aggregates activate he inflammasome. Trends Mol Med 17:276\u2013282","journal-title":"Trends Mol Med"},{"key":"4286_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-62703-724-2_14","volume":"1100","author":"FC Mohlin","year":"2014","unstructured":"Mohlin FC, Blom AM (2014) Purification and functional characterization of C4b-binding protein (C4BP). Methods Mol Biol 1100:169\u2013176","journal-title":"Methods Mol Biol"},{"key":"4286_CR15","doi-asserted-by":"crossref","first-page":"27136","DOI":"10.1074\/jbc.M102445200","volume":"29","author":"AM Blom","year":"2001","unstructured":"Blom AM, Kask L, Dahlback B (2001) Structural requirements for the complement regulatory activities of C4BP. J Biol Chem 29:27136\u201327144","journal-title":"J Biol Chem"},{"key":"4286_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-523-1_2","volume":"1040","author":"C Westwell-Roper","year":"2013","unstructured":"Westwell-Roper C, Dunne A, Kim ML, Verchere CB, Masters SL (2013) Activating the NLRP3 inflammasome using the amyloidogenic peptide IAPP. Methods Mol Biol 1040:9\u201318","journal-title":"Methods Mol Biol"},{"key":"4286_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.49.3.424","volume":"49","author":"HE Hohmeier","year":"2000","unstructured":"Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB (2000) Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424\u2013430","journal-title":"Diabetes"},{"key":"4286_CR18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/bj3230469","volume":"323","author":"Y Hardig","year":"1997","unstructured":"Hardig Y, Hillarp A, Dahlback B (1997) The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. Biochem J 323:469\u2013475","journal-title":"Biochem J"},{"key":"4286_CR19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung V, Bauernfeind F, Halle A et al (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847\u2013856","journal-title":"Nat Immunol"},{"key":"4286_CR20","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.molimm.2007.06.006","volume":"44","author":"K Li","year":"2007","unstructured":"Li K, Sacks SH, Zhou W (2007) The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol 44:3866\u20133874","journal-title":"Mol Immunol"},{"key":"4286_CR21","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A 87:5036\u20135040","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4286_CR22","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC (2004) Diabetes due to a progressive defect in \u03b2-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes. Diabetes 53:1509\u20131516","journal-title":"Diabetes"},{"key":"4286_CR23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13238-012-2924-6","volume":"3","author":"KR Mayilyan","year":"2012","unstructured":"Mayilyan KR (2012) Complement genetics, deficiencies, and disease associations. Protein Cell 3:487\u2013496","journal-title":"Protein Cell"},{"key":"4286_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","volume":"30","author":"AP Sjoberg","year":"2009","unstructured":"Sjoberg AP, Trouw LA, Blom AM (2009) Complement activation and inhibition: a delicate balance. Trends Immunol 30:83\u201390","journal-title":"Trends Immunol"},{"key":"4286_CR25","doi-asserted-by":"crossref","first-page":"9460","DOI":"10.1073\/pnas.1102356108","volume":"108","author":"NB Last","year":"2011","unstructured":"Last NB, Rhoades E, Miranker AD (2011) Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity. Proc Natl Acad Sci U S A 108:9460\u20139465","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4286_CR26","volume":"4","author":"G Lacraz","year":"2009","unstructured":"Lacraz G, Giroix MH, Kassis N et al (2009) Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat. PLoS One 4:e6963","journal-title":"PLoS One"},{"key":"4286_CR27","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1210\/en.2009-0543","volume":"150","author":"M Boni-Schnetzler","year":"2009","unstructured":"Boni-Schnetzler M, Boller S, Debray S et al (2009) Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150:5218\u20135229","journal-title":"Endocrinology"},{"key":"4286_CR28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced \u03b2 cell production of interleukin-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851\u2013869","journal-title":"J Clin Invest"},{"key":"4286_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jcp.20276","volume":"204","author":"G Papaccio","year":"2005","unstructured":"Papaccio G, Graziano A, D\u02bcAquino R, Valiante S, Naro F (2005) A biphasic role of nuclear transcription factor (NF)-\u03baB in the islet \u03b2-cell apoptosis induced by interleukin (IL)-1\u03b2. J Cell Physiol 204:124\u2013130","journal-title":"J Cell Physiol"},{"key":"4286_CR30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00032.2009","volume":"24","author":"MY Donath","year":"2009","unstructured":"Donath MY, Boni-Schnetzler M, Ellingsgaard H, Ehses JA (2009) Islet inflammation impairs the pancreatic \u03b2-cell in type 2 diabetes. Physiology (Bethesda) 24:325\u2013331","journal-title":"Physiology (Bethesda)"},{"key":"4286_CR31","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.1002854","volume":"187","author":"C Westwell-Roper","year":"2011","unstructured":"Westwell-Roper C, Dai DL, Soukhatcheva G et al (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755\u20132765","journal-title":"J Immunol"},{"key":"4286_CR32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/BF00400649","volume":"39","author":"T Mandrup-Poulson","year":"1996","unstructured":"Mandrup-Poulson T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005\u20131029","journal-title":"Diabetologia"},{"key":"4286_CR33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cmet.2014.03.001","volume":"19","author":"U Krus","year":"2014","unstructured":"Krus U, King BC, Nagaraj V et al (2014) The complement inhibitor CD59 regulates insulin secretion by modulating exocytotic events. Cell Metab 19:883\u2013890","journal-title":"Cell Metab"},{"key":"4286_CR34","volume":"3","author":"RX Li","year":"2008","unstructured":"Li RX, Chen HB, Tu K et al (2008) Localized-statistical quantification of human serum proteome associated with type 2 diabetes. PLoS One 3:e3224","journal-title":"PLoS One"},{"key":"4286_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0009-8981(89)90078-8","volume":"182","author":"H Takahashi","year":"1989","unstructured":"Takahashi H, Tatewaki W, Wada K, Shibata A (1989) Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy. Clin Chim Acta 182:195\u2013208","journal-title":"Clin Chim Acta"},{"key":"4286_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/13506129909007338","volume":"6","author":"M Nybo","year":"1999","unstructured":"Nybo M, Nielsen EH, Svehag SE (1999) Complement activation by the amyloid proteins A\u03b2 peptide and \u03b22-microglobulin. Amyloid 6:265\u2013272","journal-title":"Amyloid"},{"key":"4286_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-5-9","volume":"5","author":"DA Loeffler","year":"2008","unstructured":"Loeffler DA, Camp DM, Bennett DA (2008) Plaque complement activation and cognitive loss in Alzheimer\u2019s disease. J Neuroinflammation 5:9","journal-title":"J Neuroinflammation"},{"key":"4286_CR38","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.1101295","volume":"188","author":"BC King","year":"2012","unstructured":"King BC, Nowakowska J, Karsten CM, Kohl J, Renstrom E, Blom AM (2012) Truncated and full-length thioredoxin-1 have opposing activating and inhibitory properties for human complement with relevance to endothelial surfaces. J Immunol 188:4103\u20134112","journal-title":"J Immunol"},{"key":"4286_CR39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/emmm.201201462","volume":"4","author":"F Gil-Bea","year":"2012","unstructured":"Gil-Bea F, Akterin S, Persson T et al (2012) Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer\u02bcs disease brain. EMBO Mol Med 4:1097\u20131111","journal-title":"EMBO Mol Med"},{"key":"4286_CR40","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.molimm.2008.04.025","volume":"45","author":"LA Trouw","year":"2008","unstructured":"Trouw LA, Nielsen HM, Minthon L et al (2008) C4b-binding protein in Alzheimer\u02bcs disease: binding to A\u03b21-42 and to dead cells. Mol Immunol 45:3649\u20133660","journal-title":"Mol Immunol"},{"key":"4286_CR41","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.molimm.2008.02.023","volume":"45","author":"AP Sjoberg","year":"2008","unstructured":"Sjoberg AP, Nystrom S, Hammarstrom P, Blom AM (2008) Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly. Mol Immunol 45:3213\u20133221","journal-title":"Mol Immunol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:02:10Z","timestamp":1589752930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4286"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4286-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}